Intelligent Bio Solutions (INBS) Non Operating Investment Income (2020)
Intelligent Bio Solutions' quarterly Non Operating Investment Income came in at -$135692.0 in Q3 2020.
Intelligent Bio Solutions has reported Non Operating Investment Income for 1 years, with the latest figure at -$135692.0 in Q3 2020.
- For the quarter ending Q3 2020, Non Operating Investment Income changed N/A year-over-year to -$135692.0; the trailing twelve-month figure through Jun 2021 stood at -$135692.0 (changed N/A YoY), and the FY2021 full-year result was -$135692.0, down 211.5% from the prior year.
- Non Operating Investment Income for Q3 2020 stood at -$135692.0.
- The five-year high for Non Operating Investment Income was -$135692.0 in Q3 2020, with the low at -$135692.0 in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -55.03 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -135,692.00 |
| Sep 30, 2020 | -135,692.00 |